Pharmaceutical company and diabetes drug manufacturer Sanofi-Aventis claimed that a recent trial of their diabetes drug Lantus showed a no greater risk of retinopathy than human insulin . The study linked the diabetic drug with diabetes complication retinopathy .
The French drugmaker released a statement that reportedly said: "The results of the long-term, 5-year study of Lantus versus NPH insulin on progression of retinopathy in patients with type 2 diabetes, published on-line in Diabetologia, showed similar effects on retinopathy and overall safety in the two treatment groups."
Lantus has been heavily covered in the news recently, as several studies linked the drug to an increased risk of cancer . The Food and Drug Administration cast doubt on the studies. Lantus is a big seller for Sanofi.
Sanofi maintain diabetes drug no riskier than insulin
Mon, 06 Jul 2009
Recommended links
Diabetes insuranceDiabetes forum
Diabetes myLifestyle
Diabetes Donate
Experiment aims for diabetes therapy
Takeda diabetes drug setback
Oral insulin for type 1 diabetes prevention
Insulin receptors hold key to type 2 diabetes treatment
Diabetes : Heart Failure and Insulin Resistance Connected
Insulin pumps for diabetes could endanger teenagers, study says
Insulin for diabetes at an early stage
Inhaled insulin showing mixed results
Insulin pump works well with junior diabetics
Diabetes Sufferers Could BE Helped by Inhaling Insulin
Inhaled Insulin Could be Restricted
Oral insulin delivery one step closer
Insulin Pump Therapy for Diabetes Sufferers
News presenter happy with insulin pump
Feline diabetes needs insulin to treat
Vitamins linked to insulin and diabetes
Inhaled insulin for diabetes ceased
Diabetic girls could be skipping insulin to lose weight
NICE shift insulin goalposts for some diabetics
NHS reject diabetes oral insulin inhaler
New stem cell treatment for diabetes could replace insulin
Inhaled insulin
Diabetes Sufferers Benefit from Inhaled Insulin
Resistance to oral insulin for diabetes
Digital insulin pen for diabetes
Inhaled insulin for diabetes shunned by some doctors
UK backs Pfizer's insulin inhaler
Insulin for diabetics withdrawn from market
Intense insulin at early stage of diabetes
Reducing levels of insulin signalling to lower diabetes risk
Nasal insulin not effective for type 1 diabetes
Oral Insulin almost available in Ecuador
New Pfizer insulin inhaler hits the diabetes market
Insulin pumps for diabetes get boost
New Desang diabetes kitbags for insulin equipment
Insulin pill could control diabetes
insulin, weight loss, diabetics, diet, exercise
Eli Lilly initiate joint clinical trial for oral insulin
New insulin methods to treat diabetes
Inconsistent insulin causes diabetic deaths
Inhaled insulin a reality
Insulin mix OK for diabetic children
Join us